PROLACTIN-RELEASING EFFECT OF A NOVEL ANTI-DOPAMINERGIC DRUG, DOMPERIDONE, IN THE RAT

被引:57
作者
COCCHI, D [1 ]
GILAD, I [1 ]
PARENTI, M [1 ]
STEFANINI, E [1 ]
LOCATELLI, V [1 ]
MULLER, EE [1 ]
机构
[1] UNIV CAGLIARI,INST PHARMACOL & PHARMACOGNOSY,I-09100 CAGLIARI,ITALY
关键词
D O I
10.1159/000122977
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:65 / 69
页数:5
相关论文
共 25 条
[1]   EVIDENCE FOR DOPAMINE RECEPTOR STIMULATION BY APOMORPHINE [J].
ANDEN, NE ;
RUBENSON, A ;
FUXE, K ;
HOKFELT, T .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1967, 19 (09) :627-&
[2]   DOPAMINE IN HYPOPHYSEAL PORTAL PLASMA OF RAT DURING ESTROUS-CYCLE AND THROUGHOUT PREGNANCY [J].
BENJONATHAN, N ;
OLIVER, C ;
WEINER, HJ ;
MICAL, RS ;
PORTER, JC .
ENDOCRINOLOGY, 1977, 100 (02) :452-458
[3]  
BURT DR, 1976, MOL PHARMACOL, V12, P800
[4]  
BYCK R, 1975, PHARMACOL BASIS, P152
[5]   PROLACTIN-RELEASING EFFECT OF DOMPERIDONE IN NORMOPROLACTINEMIC AND HYPERPROLACTINEMIC SUBJECTS [J].
CAMANNI, F ;
GENAZZANI, AR ;
MASSARA, F ;
LAROSA, R ;
COCCHI, D ;
MULLER, EE .
NEUROENDOCRINOLOGY, 1980, 30 (01) :2-6
[6]  
CARLSSON A, 1963, ACTA PHARMACOL TOX, V20, P140
[7]   SUPERSENSITIVITY OF ANTERIOR-PITUITARY DOPAMINE RECEPTORS INVOLVED IN INHIBITION OF PROLACTIN SECRETION FOLLOWING DESTRUCTION OF MEDIAL BASAL HYPOTHALAMUS [J].
CHEUNG, CY ;
WEINER, RI .
ENDOCRINOLOGY, 1976, 99 (03) :914-917
[8]  
COCCHI D, 1978, LIFE SCI, V23, P927, DOI 10.1016/0024-3205(78)90219-9
[9]   EFFECT OF ERGOT DRUGS ON CENTRAL CATECHOLAMINE NEURONS - EVIDENCE FOR A STIMULATION OF CENTRAL DOPAMINE NEURONS [J].
CORRODI, H ;
FUXE, K ;
HOKFELT, T ;
LIDBRINK, P ;
UNGERSTEDT, U .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1973, 25 (05) :409-412
[10]  
COSTA E, 1977, ADV BIOCH PHARMACOL, V16